Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
How Will Proposition 35 Impact California's Medicaid Funding?
Management & Administration How Will Proposition 35 Impact California's Medicaid Funding?

California's voters will soon decide on a significant healthcare measure, Proposition 35. This proposition seeks to permanently authorize a tax on managed healthcare insurance plans, aimed at securing ongoing funding for the state's Medi-Cal program, which serves low-income residents.

Advancing Precision Medicine in Asia: Harnessing Big Data Challenges
Tech & Innovation Advancing Precision Medicine in Asia: Harnessing Big Data Challenges

As health systems in Taiwan, South Korea, and Singapore strive to advance precision medicine, they face a unique set of challenges and opportunities in leveraging big data. This article explores how these nations are overcoming obstacles to create a data-driven healthcare landscape, drawing

How Will RWJBarnabas Enhance Healthcare Access in New Jersey?
Care Providers How Will RWJBarnabas Enhance Healthcare Access in New Jersey?

RWJBarnabas Health Medical Group is taking significant strides in expanding access to healthcare in New Jersey. Recently, the group has acquired the Sanitas Medical Centers in Belleville, Elizabeth, and Union City. This development promises to enhance medical services while ensuring continuity of

What’s Delaying Innovation in the UK’s HealthTech Industry?
Management & Administration What’s Delaying Innovation in the UK’s HealthTech Industry?

The UK’s HealthTech sector, often touted as a potential beacon of global healthcare innovation, finds itself ensnared in a web of significant challenges that threaten to impede its forward momentum. The recent findings from the Association of British HealthTech Industries (ABHI) underscore r

How Is the Revenue Cycle Management Market Evolving Rapidly?
Management & Administration How Is the Revenue Cycle Management Market Evolving Rapidly?

The Revenue Cycle Management (RCM) market is experiencing a dynamic transformation. As healthcare systems become more intricate and financial operations increasingly complex, efficient revenue management is crucial. The RCM market, valued at USD 49.8 billion in 2023, is projected to reach USD 140.3

IV Solution Shortage Hits U.S. Hospitals Following Hurricane Helene
Management & Administration IV Solution Shortage Hits U.S. Hospitals Following Hurricane Helene

The healthcare sector in the United States is currently grappling with a severe shortage of intravenous (IV) solutions, a crisis triggered by the recent disruption of supply chains due to Hurricane Helene. This shortage is causing significant operational burdens on hospitals nationwide as they

Survey Reveals Costly Failures in Healthcare IT, Growing Financial Strain
Management & Administration Survey Reveals Costly Failures in Healthcare IT, Growing Financial Strain

An eye-opening survey by Black Book Market Research has exposed the increasing financial burdens that inefficient healthcare IT systems place on the industry. Gathering insights from 907 healthcare technology professionals, the study highlights technologies that not only fail to deliver expected

States Miss Key Opportunities in Medicaid Maternal Health Coverage
Management & Administration States Miss Key Opportunities in Medicaid Maternal Health Coverage

Recently, a report from the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) has highlighted missed opportunities by states to improve maternal health access through Medicaid managed care organizations (MCOs). The report points out significant gaps in insurance

Are You Ready for DSCSA Compliance and Packaging Innovations?
Management & Administration Are You Ready for DSCSA Compliance and Packaging Innovations?

The pharmaceutical industry stands at the precipice of a transformative era. As the Drug Supply Chain Security Act (DSCSA) mandates inch closer to full enforcement, stakeholders are under increasing pressure to ensure compliance. Concurrently, industry leaders are gearing up for the PACK EXPO

Can Route 92 Medical Revolutionize Stroke Treatment with New Funding?
Tech & Innovation Can Route 92 Medical Revolutionize Stroke Treatment with New Funding?

Route 92 Medical, a leader in neurovascular intervention, has successfully secured an additional $50 million, extending its Series F financing round to a total of $82 million. This significant capital injection aims to accelerate the company’s global commercialization of innovative medical devices d

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later